Renovaro Inc. - Common Stock (RENB)
0.7844
+0.0309 (4.10%)
Renovaro Inc. is a biotechnology company focused on the development of innovative therapies and solutions aimed at addressing unmet medical needs
The company specializes in advanced research and development in the field of regenerative medicine, utilizing cutting-edge technologies to create treatments that promote healing and recovery for patients suffering from various conditions. Through its commitment to scientific excellence and collaboration, Renovaro seeks to transform the healthcare landscape by bringing groundbreaking therapies from the lab to the clinic, ultimately improving patient outcomes and enhancing quality of life.
Frequently Asked Questions
Is Renovaro Inc. - Common Stock publicly traded?
Yes, Renovaro Inc. - Common Stock is publicly traded.
What exchange does Renovaro Inc. - Common Stock trade on?
Renovaro Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Renovaro Inc. - Common Stock?
The ticker symbol for Renovaro Inc. - Common Stock is RENB on the Nasdaq Stock Market
What is the current price of Renovaro Inc. - Common Stock?
The current price of Renovaro Inc. - Common Stock is 0.7844
When was Renovaro Inc. - Common Stock last traded?
The last trade of Renovaro Inc. - Common Stock was at 10:27 am EST on February 11th, 2025